Cardiovascular surveillance in breast cancer treatment: A more individualized approach is needed

Maturitas. 2016 Jul;89:58-62. doi: 10.1016/j.maturitas.2016.04.015. Epub 2016 Apr 23.

Abstract

Newly developed treatment strategies for breast cancer have reduced mortality rates over the past decades. Patients with breast cancer represent a heterogeneous population. Differences in the severity of the disease require diverse treatment options. Women have distinct individual risk patterns for cardiovascular disease that may affect their susceptibility to cardiotoxicity during therapy. While breast cancer treatment is targeted more on tumor and patient characteristics, a tailored individual approach with early and late cardiosurveillance is not yet implemented in routine care. Newly available cardiac imaging techniques are better suited to the early detection of cardiotoxicity and should be used more often in those patients at highest risk, as the early intervention afforded will improve their quality of life and prognosis.

Keywords: Breast cancer; Cardiosurveillance; Cardiotoxicity; Cardiovascular toxicity.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / diagnostic imaging*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / radiotherapy
  • Cardiovascular Diseases / diagnostic imaging*
  • Cardiovascular Diseases / etiology
  • Female
  • Humans
  • Precision Medicine

Substances

  • Antineoplastic Agents